B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand? (2020)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2665-9913(20)30270-8

PubMed Identifier: 33521659

Publication URI: http://europepmc.org/abstract/MED/33521659

Type: Journal Article/Review

Volume: 2

Parent Publication: The Lancet. Rheumatology

Issue: 10

ISSN: 2665-9913